logo

ANGIODYNAM(NSDQ:ANGO)
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company''s diverse product line includes angiographic products and accessories, dialysis products, vascular access products, PTA products, drainage products, thrombolytic products and venous products.
# Employees: 715
Address: 603 Queensbury Avenue,Queensbury,NY,USA
Phone: 518-798-1215
Fax: 518-798-3625
Website: www.angiodynamics.com
Email: info@angiodynamics.com
Sector: Medical
Industry: MED INSTRUMENTS
Executive Officers
Vincent Bucci (Chmn.; Dir.)
Eamonn P. Hobbs (Presi.; C.E.O.; Dir.)
Joseph D. Gersuk (Exec. V.P.; C.F.O.; Treas.)
Wesley Johnson (Dir.)
Howard W. Donnelly (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 8/31/2009
Next Earnings Date(Expected): 1/5/2010
Mean EPS (Next Qtr): $0.11
Mean EPS (Year): $0.46
Mean Estimate(Long Term): $13.33
P/E Ratio(Based on EPS estimate): 34.340
Number of Estimates: 9
Shares Performance
Period ANGO Compare to S&P
YTD 16.22 % -3.83 %
4 Weeks 5.36 % 0.03 %
12 Weeks 19.71 % 11.48 %
Shares Information
Analyst Coverage: Y
Avg Volume: 122825
Shares Outstanding: 24M
Market Cap: $0.39B
52 Week High: $16.19
52 Week Low: $9.85
P/E Ratio: 31.820
PEG Ratio: 2.580
Split: On 1/1/1990 ANGO split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -35.71 %
EPS Growth in Last Year: 0.00 %
Sales Growth in Last Quarter: -5.17 %
Sales Growth in Last Quarter: 13.02 %
Financials
Qtr Book Value: $1.03
Cash Flow/Share: $16.07
Change in Payout Ratio: 0.000
Price/Sales: 1.940
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia